Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prevention and Control of Healthcare-Associated Infections

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2009 by Mahidol University.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Mahidol University
ClinicalTrials.gov Identifier:
NCT00917319
First received: June 5, 2009
Last updated: June 16, 2009
Last verified: June 2009
  Purpose

Bundling infection control interventions should decrease incidence of Healthcare-Associated Infections in General Medical Wards at Siriraj Hospital, Bangkok, Thailand


Condition Intervention
Nosocomial Infection
Other: Bundling Infection Control Interventions

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Randomized Controlled Study on Effectiveness of Implementing Bundling Infection Control Interventions for Prevention and Control of Healthcare-Associated Infections in General Medical Wards at Siriraj Hospital, Bangkok, Thailand

Resource links provided by NLM:


Further study details as provided by Mahidol University:

Primary Outcome Measures:
  • Incidence of healthcare-associated infection [ Time Frame: 7 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Incidence of hospital-acquired pneumonia and catheter-associated UTI [ Time Frame: 7 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 2000
Study Start Date: January 2009
Estimated Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Infection control measure
Bundling Infection Control Interventions
Other: Bundling Infection Control Interventions
identify risk factors for developing HAIs, receive general infection control measures as well as infection control measures appropriate for the identified risk factor (s)

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • The patients hospitalized to general medical wards

Exclusion Criteria:

  • The patients hospitalized less than 48 hours
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00917319

Locations
Thailand
Department of Medicine, Faculty of Medicine Siriraj Hospital
Bangkoknoi,, Bangkok, Thailand, 10700
Sponsors and Collaborators
Mahidol University
Investigators
Principal Investigator: Visanu Thamlikitkul, MD Siriraj Hospital
  More Information

No publications provided by Mahidol University

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Visanu Thamlikitkul, Siriraj Hospital
ClinicalTrials.gov Identifier: NCT00917319     History of Changes
Other Study ID Numbers: Siriraj CEU 52-001, Siriraj Hospital
Study First Received: June 5, 2009
Last Updated: June 16, 2009
Health Authority: Thailand: Ethical Committee

Additional relevant MeSH terms:
Communicable Diseases
Cross Infection
Infection

ClinicalTrials.gov processed this record on November 20, 2014